当前位置:首页 - 行情中心 - 康华生物(300841) - 财务分析

康华生物

(300841)

  

流通市值:73.93亿  总市值:81.44亿
流通股本:1.22亿   总股本:1.35亿

康华生物(300841)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润1.49亿元,每股收益1.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益360108.61万元,未分配利润240509.72万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产420173.40万元,负债60064.79万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入311,367,042.841,577,395,401.05990,055,021.87634,439,056.46
营业总成本134,855,630.79959,259,718.87586,246,100.92363,213,245.23
营业利润172,154,952.48576,612,161.66408,526,287.21278,122,160.19
利润总额172,144,276.88573,993,594.59408,031,286.23277,895,559.11
净利润149,466,993.99509,215,964.75368,938,090.47248,204,882.62
其他综合收益----
综合收益总额149,466,993.99509,215,964.75368,938,090.47248,204,882.62
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,644,447,623.682,656,897,485.872,292,394,215.262,209,525,815.53
非流动资产合计1,557,286,354.431,552,370,826.371,622,727,048.561,596,060,691.95
资产总计4,201,733,978.114,209,268,312.243,915,121,263.823,805,586,507.48
流动负债合计588,528,448.58681,724,871.18512,332,540.97523,957,132.68
非流动负债合计12,119,405.5713,491,693.6823,848,219.8523,422,079.65
负债合计600,647,854.15695,216,564.86536,180,760.82547,379,212.33
归属于母公司股东权益合计3,601,086,123.963,514,051,747.383,378,940,5033,258,207,295.15
股东权益合计3,601,086,123.963,514,051,747.383,378,940,5033,258,207,295.15
负债和股东权益合计4,201,733,978.114,209,268,312.243,915,121,263.823,805,586,507.48
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计371,879,330.791,514,447,475.151,009,078,054630,169,726.52
经营活动现金流出小计273,289,406.07940,464,141.34744,070,537.3508,404,574.48
经营活动产生的现金流量净额98,589,924.72573,983,333.81265,007,516.7121,765,152.04
投资活动现金流入小计50,000,00050,385,340.294,0004,000
投资活动现金流出小计135,789,842.57213,774,690.48111,997,981.8884,480,593.19
投资活动产生的现金流量净额-85,789,842.57-163,389,350.19-111,993,981.88-84,476,593.19
筹资活动现金流入小计36,344,705.68221,754,880.79131,754,880.79133,154,880.79
筹资活动现金流出小计80,876,989.27228,872,244.12185,704,075.26172,108,844.92
筹资活动产生的现金流量净额-44,532,283.59-7,117,363.33-53,949,194.47-38,953,964.13
汇率变动对现金及现金等价物的影响195,146.12-69,074.39-34,770.57-1,009.56
现金及现金等价物净增加额-31,537,055.32403,407,545.999,029,569.78-1,666,414.84
期末现金及现金等价物余额1,007,828,965.841,039,366,021.16750,492,354.64634,292,060.42
最新报告期:2024-04-09
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
中信建投证券刘若飞,贺菊颖5.986.497.842024-04-09
中泰证券张楠,祝嘉琦5.165.686.502024-04-08
光大证券王明瑞5.266.016.722024-04-08
天风证券杨松5.416.58--2024-03-08
TOP↑